556 related articles for article (PubMed ID: 22677363)
1. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.
Xu S; Liu Z; Huang Y; Le K; Tang F; Huang H; Ogura S; Little PJ; Shen X; Liu P
Transl Res; 2012 Aug; 160(2):114-24. PubMed ID: 22677363
[TBL] [Abstract][Full Text] [Related]
2. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet.
Xu S; Little PJ; Lan T; Huang Y; Le K; Wu X; Shen X; Huang H; Cai Y; Tang F; Wang H; Liu P
Arch Biochem Biophys; 2011 Nov; 515(1-2):72-9. PubMed ID: 21889487
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-κB/LOX-1 pathway.
Chen B; Li J; Zhu H
Vascul Pharmacol; 2016 Oct; 85():1-10. PubMed ID: 26297684
[TBL] [Abstract][Full Text] [Related]
5. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
6. Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).
Liu Z; Xu S; Huang X; Wang J; Gao S; Li H; Zhou C; Ye J; Chen S; Jin ZG; Liu P
Br J Pharmacol; 2015 Dec; 172(23):5661-75. PubMed ID: 25572313
[TBL] [Abstract][Full Text] [Related]
7. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.
Lee JG; Lim EJ; Park DW; Lee SH; Kim JR; Baek SH
Cell Signal; 2008 Dec; 20(12):2266-75. PubMed ID: 18817866
[TBL] [Abstract][Full Text] [Related]
8. Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.
Sun Y; Chen X
Fundam Clin Pharmacol; 2011 Oct; 25(5):572-9. PubMed ID: 21077940
[TBL] [Abstract][Full Text] [Related]
9. Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression.
Thampi P; Stewart BW; Joseph L; Melnyk SB; Hennings LJ; Nagarajan S
Atherosclerosis; 2008 Apr; 197(2):620-9. PubMed ID: 17950295
[TBL] [Abstract][Full Text] [Related]
10. Tanshindiol C inhibits oxidized low-density lipoprotein induced macrophage foam cell formation via a peroxiredoxin 1 dependent pathway.
Yang Y; Li X; Peng L; An L; Sun N; Hu X; Zhou P; Xu Y; Li P; Chen J
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):882-890. PubMed ID: 29287777
[TBL] [Abstract][Full Text] [Related]
11. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
[TBL] [Abstract][Full Text] [Related]
12. Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS.
Bao MH; Zhang YW; Lou XY; Xiao Y; Cheng Y; Zhou HH
Can J Physiol Pharmacol; 2014 Apr; 92(4):299-306. PubMed ID: 24708212
[TBL] [Abstract][Full Text] [Related]
13. oxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway.
Xu Y; Kong X; Zhou H; Zhang X; Liu J; Yan J; Xie H; Xie Y
Thromb Res; 2014 Aug; 134(2):384-92. PubMed ID: 24882274
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cells.
Lei L; Li H; Yan F; Li Y; Xiao Y
J Periodontal Res; 2011 Aug; 46(4):427-37. PubMed ID: 21418223
[TBL] [Abstract][Full Text] [Related]
15. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α
Kanaoka Y; Koga M; Sugiyama K; Ohishi K; Kataoka Y; Yamauchi A
Toxicology; 2017 Apr; 380():62-71. PubMed ID: 28202387
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
17. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
Ishiyama J; Taguchi R; Yamamoto A; Murakami K
Atherosclerosis; 2010 Mar; 209(1):118-24. PubMed ID: 19782984
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase.
Sukhanov S; Snarski P; Vaughn C; Lobelle-Rich P; Kim C; Higashi Y; Shai SY; Delafontaine P
Atherosclerosis; 2015 Feb; 238(2):313-20. PubMed ID: 25549319
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
Zhao W; Ma G; Chen X
Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.
Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F
Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
